This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CVS aims to change health care delivery in $77bn acquisition of Aetna
11 Dec 2017
In a move to streamline and improve health care delivery, retail pharmacy giant and pharmaceutical benefits manager (PBM) CVS Health Corp. signed a definite agreement to buy publicly traded insurance company Aetna Inc. CVS is spending $145 in cash and issuing 0.8378 in its shares for each Aetna share, which is valued at $206 (a 16% premium). The entire agreement is worth $77bn, including the assumption of Aetna's debt. Upon deal closing, CVS stockholders will own 78% of the combined entity, and Aetna the rest.
Payment Includes Cash
Payment Includes Stock
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?